Neha Bakshi, a Histopathologist in the Department of Pathology, Histopathology Division, of Sir Ganga Ram Hospital in New Delhi, India
For weight-loss regimens: Wegovy and many compounded protocols use weekly escalations to 0.25, 0.5, 1.0, 1.7, and 2.4 mg, with each step typically held for 4 weeks to assess tolerance
For context, NICE has issued technology appraisals for semaglutide (Wegovy) for weight management and for tirzepatide (Mounjaro) for weight management, each with specific eligibility criteria based on BMI and the presence of weight-related comorbidities
L., and Hiatt, W
MITF drives transcription of melanogenic enzymes including tyrosinase, TRP-1, and TRP-2, promoting eumelanin (brown/black pigment) synthesis
It requires crossing a specific activation level to produce meaningful fat-burning effects